Heart Disease Prevention May Save Billions Annually in U.S.
Current costs of $450 billion a year aren’t sustainable, nation’s heart experts sayContinue Reading
Current costs of $450 billion a year aren’t sustainable, nation’s heart experts sayContinue Reading
But refining the risk may not change clinical practice, expert saysContinue Reading
Study found those who quit for good were more likely to be alive a year laterContinue Reading
Eliquis does not reduce heart attacks, stroke or death in high-risk patients, researchers findContinue Reading
Same factors that put heart at risk can also affect brain, according to heart and stroke associationsContinue Reading
Two-year study found the most optimistic were the least likely to have brain attackContinue Reading
Blood-thinning drug helps prevent clottingContinue Reading
Another option alongside Plavix, but should not be taken with higher doses of aspirinContinue Reading
Discontinuation was tied to 60 percent rise in risk for nonfatal attacks, researchers sayContinue Reading
Two-thirds of patients with the disorder reported experiencing a stressful trigger event, study showsContinue Reading
Within 6 hours of first signs of chest pain, 75 percent got medical help, study saysContinue Reading
But, torcetrapib, which raises ‘good’ cholesterol, showed heart risks in earlier trial that was haltedContinue Reading
Large study finds cholesterol-lowering drugs don’t increase chances of malignanciesContinue Reading
But more research needed, experts say, citing several limitations with the trialContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.